Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (201-210 of 418) with videos related to

Pageof 42
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 15, 2020
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamideConsuelo Buttigliero, Marcello Tucci, Cristina Sonetto, et al.
Cancer Treatment Reviews|February 10, 2019
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE eraMarcello Tucci, Orazio Caffo, Consuelo Buttigliero, et al.
Clinical Genitourinary Cancer|November 30, 2024
Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical OncologyIsabella Saporita, Mariangela Calabrese, Stefano Poletto, et al.
ESMO Open|April 2, 2020
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspectiveMatteo Lambertini, Angela Toss, Antonio Passaro, et al.
Clinical Genitourinary Cancer|June 6, 2018
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line DocetaxelConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.
Expert Review of Anticancer Therapy|February 10, 2012
Cetuximab in non-small-cell lung cancerGuido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Clinical and Translational Radiation Oncology|September 7, 2018
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamideMarco C Merlano, Anna M Merlotti, Lisa Licitra, et al.
Clinical Lung Cancer|February 4, 2014
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Filippo de Marinis, Federico Cappuzzo, et al.
Critical Reviews in Oncology/Hematology|November 25, 2022
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factorsMarco Donatello Delcuratolo, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology|April 14, 2022
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?Marco Audisio, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Pageof 42

Showing results (201-210 of 418) with videos related to

Sort By:
Pageof 42
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 15, 2020
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamideConsuelo Buttigliero, Marcello Tucci, Cristina Sonetto, et al.
Cancer Treatment Reviews|February 10, 2019
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE eraMarcello Tucci, Orazio Caffo, Consuelo Buttigliero, et al.
Clinical Genitourinary Cancer|November 30, 2024
Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical OncologyIsabella Saporita, Mariangela Calabrese, Stefano Poletto, et al.
ESMO Open|April 2, 2020
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspectiveMatteo Lambertini, Angela Toss, Antonio Passaro, et al.
Clinical Genitourinary Cancer|June 6, 2018
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line DocetaxelConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.
Expert Review of Anticancer Therapy|February 10, 2012
Cetuximab in non-small-cell lung cancerGuido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Clinical and Translational Radiation Oncology|September 7, 2018
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamideMarco C Merlano, Anna M Merlotti, Lisa Licitra, et al.
Clinical Lung Cancer|February 4, 2014
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Filippo de Marinis, Federico Cappuzzo, et al.
Critical Reviews in Oncology/Hematology|November 25, 2022
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factorsMarco Donatello Delcuratolo, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology|April 14, 2022
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?Marco Audisio, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Pageof 42